which lack this domain can bind SRF but not activate transcription. Consistent with this idea, LexA fusion proTo assess the role of MAL in Rho-actin signaling to SRF more directly, we examined its effect on serumteins containing the MAL C-terminal sequences strongly activated a LexA reporter gene; however, serum stimulainduced transcription. At low expression levels, MAL (met) substantially potentiated serum-induced SRF retion did not alter transcriptional activation by these fusions ( Figure 3F ). porter activity, and at high expression level also strongly stimulated reporter activity in serum-starved cells (Figure 3C) . Expression of C3 transferase, which ADP-riboNuclear Accumulation of MAL Requires Rho-Actin Signaling sylates and inactivates Rho, strongly inhibited reporter activation by MAL(met) in both serum-starved and -stimWe next tested the ability of known inhibitors of Rhoactin signaling and other pathways to inhibit serumulated cells ( Figure 3D 
MAL Associates with Actin via the RPEL Motifs
The results presented above show that inhibition of Rhofrom phosphorylation; this may occur at serine or threonine residues, since MAL did not react with anti-phosactin signaling or overexpression of actin itself can inhibit nuclear translocation of MAL through a mechanism photyrosine antibodies ( Figure 5C, top) . To assess the relevance of Rho and Ras signaling for MAL phosphorydependent on the integrity of the N-terminal RPEL motifs. We therefore investigated whether this reflects the lation, we used C3 transferase coexpression and U0126 treatment to inactivate Rho-actin and MEK-ERK signalassociation of MAL with actin in vivo. First, mutant actins designed to localize to novel cellular locations were coning, respectively. Inactivation of Rho substantially reduced but did not prevent the serum-induced increase structed and their ability to alter the localization of coexpressed MAL(met) tested by immunofluorescence in MAL M r , while U0126 had a lesser effect; treatment of C3-expressing cells with U0126, however, abolished assay. Wild-type actin or nonpolymerizable actin R62D tagged with the SV40 NLS efficiently accumulated in the it ( Figure 5C, center) . A PKC inhibitor, bisindolylmaleimide, had no effect ( Figure 5C, center) . Both Rho and nucleus, and in the presence of these actins coex- pressed MAL(met) was also nuclear, even in the absence MAL⌬N⌬B1, MAL(met)⌬B1B2, and MAL(met)⌬B1 (see Figure 5A ). We reasoned that these mutants might seof signal (Figure 6A, top; Figures 2A and 2D) . We used immunofluorescence assays to test whether cells, presumably at the Golgi, as did coexpressed MAL (met) (Figure 6A, bottom) 
